Kostikas, KonstantinosPrice, DavidGutzwiller, Florian S.Jones, BethanLoefroth, EmilClemens, AndreasFogel, RobertJones, RupertCao, Hui2020-07-162020-07-162020-07-16Kostikas, K, Price, D, Gutzwiller, F S, Jones, B, Loefroth, E, Clemens, A, Fogel, R, Jones, R & Cao, H 2020, 'Clinical impact and healthcare resource utilization associated with early versus late COPD diagnosis in patients from UK CPRD database', International journal of chronic obstructive pulmonary disease , vol. 2020, no. 15, pp. 1729-1738. https://doi.org/10.2147/COPD.S2554141176-9106https://hdl.handle.net/2164/14718Funding The study was funded by Novartis AG, Basel, Switzerland. Acknowledgments Editorial and writing support was provided by Santanu Bhadra and Harneet Kaur (Novartis), funded by Novartis AG, Basel, Switzerland, in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org/gpp3). Data analysis was conducted by Pharmatelligence.10293460engSDG 3 - Good Health and Well-beingChronic obstructive pulmonary disease/COPDClinical Practice Research Datalink/UK-CPRDearly diagnosis of COPDlate diagnosis of COPDhealthcare utilizationUK-CPRDClinical practice research datalinkLate diagnosis of COPDChronic obstructive pulmonary diseaseEarly diagnosis of COPDHealthcare utilizationCOPDOBSTRUCTIVE PULMONARY-DISEASEclinical practice research datalinkchronic obstructive pulmonary diseaseR Medicine (General)Public Health, Environmental and Occupational HealthHealth PolicyPulmonary and Respiratory MedicineR1Journal article10.2147/COPD.S255414http://www.scopus.com/inward/record.url?scp=85088014141&partnerID=8YFLogxK15